Target intelligence / Profile preview

Cytomegalovirus Antigen pp65 (pp65)

Target
pp65
Molecular classification
Viral protein, Tegument protein, Phosphoprotein
01

Overview

Cytomegalovirus antigen pp65 (pp65 or UL83) is the major structural protein of human cytomegalovirus (HCMV). It plays a key role in modulating host immune responses by inhibiting interferon production and participating in transactivation of viral genes. pp65 is an immunodominant antigen recognized by T cells, making it a valuable target for diagnostic assays, immune monitoring, and vaccine development, although it may not be sufficient as a single target for effective vaccine-induced immunity.

Other names
Phosphoprotein UL83Tegument Protein UL8365 kDa matrix phosphoproteinUL83
02

Biological functions

Immune evasionInhibition of IRF3Immediate early gene transactivationModulation of interferon response
03

Disease associations

Cytomegalovirus infectionInfection in immunocompromised patients
04

Safety considerations

Targeting pp65 alone may not provide full protection against HCMV
05

Biomarkers

pp65 antigenemia for CMV infection diagnosisCMV-specific T cell responses

Beyond the preview

Go deeper on Cytomegalovirus Antigen pp65 (pp65).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytomegalovirus Antigen pp65 (pp65).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call